Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
Clinical trial NCT04840615 · TERMINATED
Trial details
- NCT number
- NCT04840615
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2021-12-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.